A South Korean research team has developed a strip-type urine test that successfully diagnoses prostate and pancreatic cancer on-site by amplifying the optical signal of the metabolome in urine.
The joint research team is from the Korea Institute of Materials Science, Pohang University of Science and Technology, and Kyung Hee University
The surface-enhanced Raman scattering sensor that they developed can amplify the optical signal of the metabolome in urine by more than 1 billion times by forming a coral reef-shaped plasmonic nanomaterial on top of porous paper material.
A light irradiation after a 10-microliter urine droplet amplified signal of cancer metabolome on the sensor’s surface without the need to go through a separate analysis process,.
The application of an artificial intelligence-based analytical method for the spectrum signal generated through the irradiation of light into the urine can identify people with prostate cancer and pancreatic cancer with an accuracy of up to 99 percent.


Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone
NASA Resumes Cygnus XL Cargo Docking with Space Station After Software Fix
Trump to Visit China for Key U.S.-China Summit With Xi Jinping
TikTok Nears $400 Million Settlement With Trump Administration Over Child Privacy Lawsuit
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
RFK Jr. Expands CDC Vaccine Advisory Panel's Scope Amid Legal Battles
FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims
Trump Invites Top CEOs Including Nvidia, Apple, Boeing to China Summit With Xi Jinping
Morgan Stanley Bets on Optical Component Stocks in Greater China Tech Sector
Hantavirus Cruise Ship Outbreak Triggers Global Health Alert
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma
Judge Delays SEC Settlement With Elon Musk Over Twitter Stock Disclosure Case 



